image
Y-mAbs Therapeutics, Inc. YMAB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.41
-4.75 %
$ 200 M
Market Cap
-6.89
P/E
Price Target Average
324.36%
Revenue Forecast Estimate
19.86%
EBIT Estimate
--43.53%
Net Income Estimate
--4.69%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Y-mAbs Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for YMAB of $18.7 , with forecasts ranging from a low of $7 to a high of $26 .
YMAB Lowest Price Target Wall Street Target
7 USD 58.73%
YMAB Average Price Target Wall Street Target
18.7 USD 324.36%
YMAB Highest Price Target Wall Street Target
26 USD 489.57%
Price
Max Price Target
Min Price Target
Average Price Target
303025252020151510105500Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart YMAB

image
$200.0m$200.0m$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart YMAB

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart YMAB

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029